More Anatara Lifesciences Ltd news
Anatara Lifesciences LtdASX: ANR

Exclusive Global License Agreement with Zoetis

May 15, 2018 at 12:11 AM EDT · Issued by Anatara Lifesciences Ltd

Filed with ASX · May 15, 2018 at 12:11 AM EDT

On 6ix: 6ix.com/news/exclusive-global-license-agreement-with-zoetis

Anatara Lifesciences Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Anatara Lifesciences Ltd on 6ix

In the deck

  • Anatara Lifesciences — Investor Presentation (May 2018)22 slidesMay 16, 2018

Story so far

  • ANR and Zoetis to negotiate International Detach CommercialAug 21, 2017
  • Zoetis Second Payment is receivedJan 30, 2017
  • Zoetis Exclusive Research Evaluation and License OptionFeb 11, 2016

Earlier from Anatara Lifesciences

  • FDA approves the Human Food Safety DossierFeb 4, 2018
  • R&D Tax Incentive ReceivedJan 17, 2018
  • Pork CRC Options extended by 12 MonthsSep 12, 2017
  • Preliminary Final ReportAug 30, 2017
  • ANR and Zoetis to negotiate International Detach CommercialAug 20, 2017

Later from Anatara Lifesciences

  • Anatara CEO announces retirementMay 16, 2018
  • Investor Presentation and Strategy UpdateJul 18, 2018
  • Appendix 4E & Audited Financial StatementsAug 31, 2018
  • APVMA approval for DetachOct 28, 2018
  • Chief Executive Officer AppointmentNov 13, 2018
All Anatara Lifesciences news releases↗

Follow Anatara Lifesciences into a list and get an email when it puts out news.

Follow Anatara Lifesciences
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer